<DOC>
	<DOCNO>NCT01857063</DOCNO>
	<brief_summary>This study evaluate efficacy safety montelukast ( MK-0476 ) treatment Japanese pediatric participant seasonal allergic rhinitis ( SAR ) . The primary hypothesis study montelukast superior placebo treatment nasal symptom SAR .</brief_summary>
	<brief_title>Study Efficacy Safety MK-0476 Japanese Pediatric Participants With Seasonal Allergic Rhinitis ( MK-0476-519 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Weight : ≥ 25 kg Height : ≥ 125 cm Able record symptom diary Has allergic rhinitis symptom [ Japanese Cedar ( JC ) pollinosis ] Tested positive JC pollen specific immunoglobulin E ( IgE ) antibody assay Has nasal finding would interfere evaluate nasal congestion symptom Past present medical history bronchial asthma Medical history allergy except allergic rhinitis possibility dramatically worsen symptom induce JC pollen exposure</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>